Researchers recommend monitoring patients' mental state

Patients with squamous cell non-small cell lung cancer who got nivolumab lived longer, had fewer side effects

Damage to thinking and memory less than with radiation for entire brain, while survival is similar, study finds

Damage to thinking and memory less than with radiation for entire brain, while survival is similar, study finds

Compared to Yervoy, nivolumab more than doubled time to disease progression, researchers found

Fewer die of 'late effects' from radiation, chemotherapy, study finds

DNA-modified virus serves as decoy to help target and destroy glioblastoma cells, researchers say

No survival difference seen for patients spared surgery, study says

Ibrutinib, obinutuzumab slowed progression of common leukemia, non-Hodgkin lymphoma

Study suggests that taking more tissue the first time might reduce need for subsequent procedures